BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 11893634)

  • 1. Tuberculosis of abdominal lymph nodes, peritoneum, and GI tract: a malignancy mimic.
    Das CJ; Vora Z; Sharma R; Addula D; Kundra V
    Abdom Radiol (NY); 2022 May; 47(5):1775-1787. PubMed ID: 35292843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis spine: Therapeutically refractory disease.
    Jain AK; Dhammi IK; Modi P; Kumar J; Sreenivasan R; Saini NS
    Indian J Orthop; 2012 Mar; 46(2):171-8. PubMed ID: 22448055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation-corrected vs. nonattenuation-corrected 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in oncology: a systematic review.
    Joshi U; Raijmakers PG; Riphagen II; Teule GJ; van Lingen A; Hoekstra OS
    Mol Imaging Biol; 2007; 9(3):99-105. PubMed ID: 17318671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern diagnosis of lung nodules].
    Abolmaali ND; Vogl TJ
    Radiologe; 2004 May; 44(5):472-83. PubMed ID: 15168025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of sodium iodide based (18)F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses.
    Pitman AG; Hicks RJ; Binns DS; Ware RE; Kalff V; McKenzie AF; Ball DL; MacManus MP
    Br J Radiol; 2002 Feb; 75(890):114-21. PubMed ID: 11893634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography in lung cancer.
    Nomori H; Ohba Y; Yoshimoto K; Shibata H; Shiraishi K; Mori T
    Gen Thorac Cardiovasc Surg; 2009 Apr; 57(4):184-91. PubMed ID: 19367450
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.